lincomycin
Lincomycin Injection, USP
Approved
Approval ID
7efe038a-8d67-4151-864a-b4863b46643e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 24, 2023
Manufacturers
FDA
Slate Run Pharmaceuticals, LLC
DUNS: 039452765
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
lincomycin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70436-035
Application NumberANDA216662
Product Classification
M
Marketing Category
C73584
G
Generic Name
lincomycin
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJanuary 24, 2023
FDA Product Classification
INGREDIENTS (2)
LINCOMYCINActive
Quantity: 300 mg in 1 mL
Code: BOD072YW0F
Classification: ACTIB
BENZYL ALCOHOLInactive
Quantity: 9.45 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
lincomycin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70436-034
Application NumberANDA216662
Product Classification
M
Marketing Category
C73584
G
Generic Name
lincomycin
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJanuary 24, 2023
FDA Product Classification
INGREDIENTS (2)
BENZYL ALCOHOLInactive
Quantity: 9.45 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
LINCOMYCINActive
Quantity: 300 mg in 1 mL
Code: BOD072YW0F
Classification: ACTIB